x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

40:24

Experts discuss how endotyping and biomarkers can...

touchPODCAST ·

2021/12/03

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma. The experts Dr Katharine Woessner, Scripps Clinic Medical Group, San Diego, CA, USA Prof. Louis-Philippe Boulet, Laval University, Quebec City, Canada Prof. Arnaud Bourdin,

en

40:23

Experts discuss how endotyping and biomarkers can...

touchPODCAST ·

2021/12/03

touchPANEL DISCUSSION for touchRESPIRATORY Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma. The experts Dr Katharine Woessner, Scripps Clinic Medical Group, San Diego, CA, USA Prof. Louis-Philippe Boulet, Laval University, Quebec City, Canada Prof. Arnaud Bourdin,

en

37:51

Improving outcomes for patients with NTM-LD

touchPODCAST ·

2021/11/30

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to leading experts consider how to optimize the diagnosis of nontuberculous mycobacterial lung disease (NTM-LD) and how to manage it considering the latest treatment guidelines. The experts Dr Juzar Ali, LSU Health Sciences Center, New Orleans, LA, USA Dr Doreen Addrizzo-Harris, NYU Grossman School of Medicine, New York, NY, USA Dr Kevin Winthrop, Oregon Health & Science University, Portland, OR, USA This touchPODCAST is for HCPs only. This

en

37:49

Improving outcomes for patients with NTM-LD

touchPODCAST ·

2021/11/30

touchEXPERT OPINIONS for touchRESPIRATORY Listen to leading experts consider how to optimize the diagnosis of nontuberculous mycobacterial lung disease (NTM-LD) and how to manage it considering the latest treatment guidelines. The experts Dr Juzar Ali, LSU Health Sciences Center, New Orleans, LA, USA Dr Doreen Addrizzo-Harris, NYU Grossman School of Medicine, New York, NY, USA Dr Kevin Winthrop, Oregon Health & Science University, Portland, OR, USA This touchPODCAST is for HCPs only. This activity

en

38:35

Achieving sustained outcomes for moderate-to-severe...

touchPODCAST ·

2021/11/30

touchTALKS for touchIMMUNOLOGY This touchPODCAST is presented by Dr Melinda Gooderham, SKiN Centre for Dermatology, Peterborough, Ontario, Canada. Listen to Dr Gooderham present the latest data and future directions of systemic therapy for moderate-to-severe atopic dermatitis and how effective treatment can achieve sustained control of symptoms and improve the quality of life of patients and their families. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent

en

18:46

Perspectives on the latest clinical data for targeted...

touchPODCAST ·

2021/11/30

touchMDT for touchONCOLOLOGY Listen to key experts from a multidisciplinary team discuss the latest efficacy and safety data for targeted therapies for thyroid cancer The multidisciplinary team Endocrinologist: Dr Antonio Matrone, Italy Nurse specialist: Ms Tara Hurley, UK Oncologist: Dr Lori Wirth, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and

en

17:36

Perspectives on biomarker testing and its influence...

touchPODCAST ·

2021/11/30

touchMDT for touchONCOLOLOGY Listen to key experts from a multidisciplinary team explore the use of biomarkers in thyroid cancer care and how personalized medicine influences patient outcomes The multidisciplinary team Pathologist: Dr Peter Sadow, USA Endocrinologist: Dr Antonio Matrone, Italy Oncologist: Dr Lori Wirth, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided

en

16:34

An overview of thyroid cancers from a MDT of experts

touchPODCAST ·

2021/11/30

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team (MDT) discuss the epidemiology of thyroid cancer, available treatment options, and the role of the MDT in patient care The multidisciplinary team Oncologist: Dr Lori Wirth, USA Endocrinologist: Dr Antonio Matrone, Italy Nurse specialist: Ms Tara Hurley, UK Pathologist: Dr Peter Sadow, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly and

en

30:20

Expert opinions on the management of EDS due to OSA...

touchPODCAST ·

2021/11/29

touchEXPERT OPINIONS for touchNEUROLOGY Listen to leading sleep medicine experts discuss strategies for the optimal management of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) or narcolepsy, and share insights and potential implications for clinical practice. The experts Dr Annamaria Iakovou – Northwell Health, Lake Success, New York, NY, USA Prof. Helene A Emsellem – Center of Sleep & Wake Disorders, Chevy Chase, MD, USA Prof. Gert Jan Lammers – Sleep-Wake Centres

en

30:21

Expert opinions on the management of EDS due to OSA...

touchPODCAST ·

2021/11/29

touchEXPERT OPINIONS for touchRESPIRATORY Listen to leading sleep medicine experts discuss strategies for the optimal management of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) or narcolepsy, and share insights and potential implications for clinical practice. The experts Dr Annamaria Iakovou – Northwell Health, Lake Success, New York, NY, USA Prof. Helene A Emsellem – Center of Sleep & Wake Disorders, Chevy Chase, MD, USA Prof. Gert Jan Lammers – Sleep-Wake

en

11:59

Evolving Standards Of Patient Care in Hepatocellular...

touchPODCAST ·

2021/11/29

touchMDT for touchONCOLOGY Listen to a multidisciplinary tumour board consider the potential of systemic therapy in hepatocellular carcinoma during the current immunotherapy era. The multidisciplinary team Medical oncologist: Prof. Ahmed Kaseb, USA Radiation oncologist: Prof. Jinsil Seong, Korea Hepatologist: Prof. Peter Galle, Germany Surgical oncologist: Dr Michael Choti, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from

en

11:56

Evolving Standards Of Patient Care in Hepatocellular...

touchPODCAST ·

2021/11/29

touchMDT for touchONCOLOGY Listen to a multidisciplinary tumour board discuss how recent developments are enabling the management of patients with hepatocellular carcinoma to become increasingly individualized. The multidisciplinary team Medical oncologist: Prof. Ahmed Kaseb, USA Radiation oncologist: Prof. Jinsil Seong, Korea Hepatologist: Prof. Peter Galle, Germany Surgical oncologist: Dr Michael Choti, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical

en

11:16

Evolving Standards Of Patient Care in Hepatocellular...

touchPODCAST ·

2021/11/29

touchMDT for touchONCOLOGY Listen to a multidisciplinary tumour board share their perspectives on a best practice multidisciplinary approach to patient care in the management of hepatocellular carcinoma. The multidisciplinary team Medical oncologist: Prof. Ahmed Kaseb, USA Radiation oncologist: Prof. Jinsil Seong, Korea Hepatologist: Prof. Peter Galle, Germany Surgical oncologist: Dr Michael Choti, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent

en

31:20

Choosing IOLs for patients with cataracts: Insights...

touchPODCAST ·

2021/11/25

touchEXPERT OPINIONS for touchOPHTHALMOLOGY Listen to expert insights on how novel IOLs can address patients’ visual needs, the factors that influence IOL selection and managing patient expectations. The expert Dr Rosa Braga-Mele - Professor of Ophthalmology, Faculty of Medicine at the University of Toronto, Canada. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Alcon Laboratories Inc. This activity is jointly provided by USF

en

33:52

Experts discuss the latest data for emerging...

touchPODCAST ·

2021/11/10

touchPANEL DISCUSSION for touchONCOLOGY Listen as leading experts discuss the latest clinical data for emerging HER2-directed therapies and review novel therapeutic strategies and consider the implications for clinical practice. The experts Dr Laura Biganzoli – Department of Oncology, Hospital of Prato, Prato, Italy Dr Peter Fasching – Comprehensive Cancer Center, Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany Dr Sonia Pernas – Catalan Institute of Oncology, and

en

11:44

Making the case for the MDT in NSCLC

touchPODCAST ·

2021/11/10

touchMDT for touchONCOLOGY Listen to a medical oncologist, a pathologist, a radiation oncologist and an oncology nurse practitioner discuss how to optimize treatment decisions, taking into account emerging therapies as well as patient expectations and preferences. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA Pathologist: Prof. Keith Kerr, UK Radiation oncologist: Prof. Andrea Bezjak, Canada Oncology nurse practitioner: Dr Marianne Davies, USA This touchPODCAST is for

en

11:43

The role of biomarker testing in NSCLC

touchPODCAST ·

2021/11/10

touchMDT for touchONCOLOGY Listen to a medical oncologist and a pathologist discuss the evolving role of biomarker testing in NSCLC in the light of emerging testing methodologies and treatment targets. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA Pathologist: Prof. Keith Kerr, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics, Regeneron Pharmaceuticals,

en

12:10

Navigating treatment decisions in NSCLC

touchPODCAST ·

2021/11/10

Listen to a medical oncologist, a pathologist and an oncology nurse practitioner discuss the evolving treatment landscape and how treatment decisions need to take into account potential side effects. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA Pathologist: Prof. Keith Kerr, UK Oncology nurse practitioner: Dr Marianne Davies, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co Ltd, Turning Point

en

11:34

Initial assessment of NSCLC

touchPODCAST ·

2021/11/10

touchMDT for touchONCOLOGY Listen to a medical oncologist and a radiation oncologist discuss the importance of the initial assessment in NSCLC and the role of the different members of the multidisciplinary team. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA Radiation oncologist: Prof. Andrea Bejzak, Canada This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics,

en

34:12

Experts discuss the emerging role of SERDs in HR+...

touchPODCAST ·

2021/11/05

touchPANEL DISCUSSION for touchONCOLOGY Listen to leading experts review the latest advances in HR+ breast cancer, focusing on the management of specific patient subgroups and the potential impact of emerging oral, second-generation SERDs on patient standard of care. The experts Prof. Hope S Rugo – UCSF Comprehensive Cancer Center, San Francisco, CA, USA Dr Fatima Cardoso – Champalimaud Clinical Center, Lisbon, Portugal Dr Matti Aapro – Genolier Cancer Center, Genolier, Switzerland This

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter